Ituran Q2 Strength Counters Slowdown Fears, But OEM Conversion Proof Still Missing

What happened

Ituran reported Q2 revenue up 21% and net income up 29%, demonstrating robust operating momentum. Despite these results, shares trade at 15x 2026E earnings with a 3.7% dividend yield and a net cash balance, suggesting the market has not fully rewarded the growth. The growth is driven by OEM partnerships, notably with Stellantis in Brazil, which are expanding the recurring subscription base. However, the deep-value master report had assigned a WAIT rating pending disclosure of OEM paid conversions and churn metrics, as historical churn runs about 3% monthly and most customers can cancel at will. The news article highlights big data and IturanMob as additional upside, but without concrete KPI data from the company, the fundamental risk of unproven OEM monetization remains.

Implication

Investors should view the strong Q2 as a positive data point that reduces near-term downside risk, but the stock's valuation at 15x forward earnings already reflects a moderate growth expectation. The dividend yield and net cash provide a cushion, making the stock attractive for income-focused investors, but capital appreciation will require evidence of sustainable subscriber growth from OEM programs. The next two quarterly reports will be critical: if management discloses OEM paid conversions and churn remains near historical levels, the investment case strengthens and the stock could re-rate higher. Conversely, if churn rises or OEM free-trial conversions disappoint, the stock could face multiple compression toward the bear case value of $46. Until those metrics are provided, a disciplined approach suggests maintaining a modest position or waiting for a pullback toward the attractive entry level of $52.

Thesis delta

The strong Q2 results slightly improve the risk-reward, but the core thesis remains unchanged: Ituran needs to prove that OEM programs convert to paid subscriptions and that churn remains controlled. The master report's WAIT rating was predicated on pending KPI disclosure, and this news does not provide that disclosure. Therefore, the thesis delta is that the positive fundamentals increase confidence in the base case, but the key catalysts for a rating upgrade are still outstanding.